Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Walsh

Showing results (41-50 of 259) with videos related to

Pageof 26
Sort By:
Antimicrobial Agents and Chemotherapy|August 26, 2003
Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosaMark A Toleman, Kenneth Rolston, Ronald N Jones, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2005
Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strainsMandy Wootton, Peter M Bennett, Alasdair P MacGowan, et al.
Infection Control and Hospital Epidemiology|February 10, 2009
Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureusMandy Wootton, Timothy R Walsh, Eleri M Davies, et al.
Diagnostic Microbiology and Infectious Disease|November 18, 2005
Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004)Douglas J Biedenbach, Mark Toleman, Timothy R Walsh, et al.
The Lancet. Infectious Diseases|September 26, 2020
Use of polymyxins in Chinese hospitalsRong Zhang, Yingbo Shen, Timothy R Walsh, et al.
The Journal of Biological Chemistry|April 25, 2008
Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptidesAyman Hawrani, Robin A Howe, Timothy R Walsh, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United StatesMark A Toleman, Kenneth Rolston, Ronald N Jones, et al.
Plos Medicine|July 3, 2023
Antimicrobial Resistance: Addressing a Global Threat to HumanityTimothy R Walsh, Ana C Gales, Ramanan Laxminarayan, et al.
Journal of Clinical Microbiology|November 17, 2006
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptidesMandy Wootton, Alasdair P MacGowan, Timothy R Walsh, et al.
China CDC Weekly|February 8, 2023
Minimizing Risks of Antimicrobial Resistance Development in the Environment from a Public One Health PerspectiveYu Zhang, Timothy R Walsh, Yang Wang, et al.
Pageof 26

Showing results (41-50 of 259) with videos related to

Sort By:
Pageof 26
Antimicrobial Agents and Chemotherapy|August 26, 2003
Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosaMark A Toleman, Kenneth Rolston, Ronald N Jones, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2005
Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strainsMandy Wootton, Peter M Bennett, Alasdair P MacGowan, et al.
Infection Control and Hospital Epidemiology|February 10, 2009
Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureusMandy Wootton, Timothy R Walsh, Eleri M Davies, et al.
Diagnostic Microbiology and Infectious Disease|November 18, 2005
Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004)Douglas J Biedenbach, Mark Toleman, Timothy R Walsh, et al.
The Lancet. Infectious Diseases|September 26, 2020
Use of polymyxins in Chinese hospitalsRong Zhang, Yingbo Shen, Timothy R Walsh, et al.
The Journal of Biological Chemistry|April 25, 2008
Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptidesAyman Hawrani, Robin A Howe, Timothy R Walsh, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United StatesMark A Toleman, Kenneth Rolston, Ronald N Jones, et al.
Plos Medicine|July 3, 2023
Antimicrobial Resistance: Addressing a Global Threat to HumanityTimothy R Walsh, Ana C Gales, Ramanan Laxminarayan, et al.
Journal of Clinical Microbiology|November 17, 2006
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptidesMandy Wootton, Alasdair P MacGowan, Timothy R Walsh, et al.
China CDC Weekly|February 8, 2023
Minimizing Risks of Antimicrobial Resistance Development in the Environment from a Public One Health PerspectiveYu Zhang, Timothy R Walsh, Yang Wang, et al.
Pageof 26